Kyntra Bio (KYNB) Revenue (2014 - 2026)
Kyntra Bio (KYNB) posted Revenue of $3.7 million for Q1 2026, up 192.72% sequentially from $1.3 million in Q4 2025, and up 36.47% YoY from $2.7 million in Q1 2025.
Kyntra Bio (KYNB) Revenue (2014 - 2026) Analysis & Trends
Kyntra Bio has reported Revenue for 13 years, with the latest figure at $3.7 million in Q1 2026.
- Quarterly Revenue rose 36.47% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.4 million (up 16.29% YoY) and the FY2025 annual result came in at $6.4 million, down 78.26% from the prior year.
- Revenue rose to $3.7 million in Q1 2026 per KYNB's latest filing, from $1.3 million in the prior quarter.
- Over five years, Revenue peaked at $40.1 million in Q3 2023 and troughed at -$73.8 million in Q4 2023.
- A 5-year average of $3.7 million and a median of $2.7 million in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2023 and 2025: Revenue tumbled 978.7% in 2023, then soared 774.8% in 2025.
- Over 5 years, Revenue stood at $8.4 million in 2022, then sank by 978.7% to -$73.8 million in 2023, then surged by 104.25% to $3.1 million in 2024, then tumbled by 59.27% to $1.3 million in 2025, then soared by 192.72% to $3.7 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $3.7 million, $1.3 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.47 Mn |
| Mar 31, 2026 | 3.74 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 123,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 2.20 Mn |
| Dec 31, 2023 | -73.81 Mn |
| Sep 30, 2023 | 40.13 Mn |
| Jun 30, 2023 | 14.40 Mn |
| Mar 31, 2023 | 1.70 Mn |
| Dec 31, 2022 | 8.40 Mn |
| Sep 30, 2022 | 15.74 Mn |
| Jun 30, 2022 | 29.81 Mn |
| Mar 31, 2022 | 9.80 Mn |
| Dec 31, 2021 | 16.54 Mn |
| Sep 30, 2021 | 155.97 Mn |